Daniel J Starks

Director

Daniel J Starks (Director) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales), most often in Abbott Laboratories (ABT). Across 2 priced purchase filings, the average 21-session return was -1.9% from execution and -3.2% from disclosure (delay-adjusted; derived). The largest single filing was $1.1M of ABT (10,000 sh across 2 lots, as filed), executed Feb 4.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

-1.9%

avg across 2 priced filings

Delay-adjustediThe same average, entered at disclosure dates

-3.2%

same 2 filings, from disclosure

Filings, ttm

2 buys · 0 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.0M

shares × price, as filed

Last traded

Apr 27

Filed Apr 28

Median ADV $1.4B across their filed names

Open performance→

Volume by month

Buys $2.0M Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names

ABT

Abbott Laboratories ABT · 2 buys · 0 sells 2 filings

Recent filings

ABTPURCHASE Abbott Laboratories View filing → $927K
10,000 sh × $92.65
Exec Apr 27
Filed Apr 28 · 7:37 PM ET ABTPURCHASE Abbott Laboratories View filing → $1.1M
10,000 sh across 2 lots
Exec Feb 4
Filed Feb 6 · 8:04 AM ET